Combatting Substandard and Falsified Medicines
Public Awareness and Identification of Counterfeit Medications
Bibliographic Data
| ID | 22073021 |
|---|---|
| Authors | Faris El‐Dahiyat (0000-0002-5264-8699, Al Ain University, corresponding author), Faris El-Dahiyat, Khairi M S Fahelelbom, Khairi Mustafa Fahelelbom (0000-0003-3730-8132, Al Ain University), Ammar Abdulrahman Jairoun (0000-0002-4471-0878, Dubai Health Authority), Sabaa Saleh Al‐Hemyari (0000-0002-0795-3408), Sabaa Saleh Al-Hemyari |
| Year | 2021 |
| Volume | 9 |
| Pages | 754279-754279 |
| Publication date | 2021-10-26 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2021.754279 |
| PMID | 34765583 |
| OpenAlex | W3208251584 |
| Language | EN |
| Citations received | 2 |
| References cited | 19 |
Objectives: The objective of this study was to determine the identification rate of substandard and falsified medications and its association with knowledge among public. Methods: This descriptive cross-sectional study was conducted in different geographic areas among a convenient sample of people aged 18 or older. A validated web-based electronic questionnaire was used for data collection tool. The questionnaire contained three sections assessing the following: (1) Sociodemographic data; (2) Knowledge regarding counterfeit medicines; and (3) Ability to identify counterfeit medicines, according to 12 questions rated on a five-point Likert scale. Univariate and multivariate logistic regression analyses were used to assess the association between sociodemographic factors and counterfeit medication identification rate. Results: A total of 320 people participated in the study. Only 98 participants (30.6%, 95% CI 25.6–35.7%) identified the counterfeit medications. Ability to correctly identify counterfeit medications was significantly higher in participants who were older ( p = 0.016), single ( p = 0.001), Asian ( p = 0.001), or American ( p = 0.019), as well as those who indicated that they would check the certification of the medications ( p = 0.015) and report counterfeit medications to the authorities ( p < 0.0001). Conclusions: These results underscore the need for greater public awareness of the hazards associated with counterfeit medicines
Counterfeit · Counterfeit Drugs · Cross-sectional study · Descriptive statistics · Environmental health · Family medicine · Geography · Likert scale · Logistic regression · Public health · Intellectual Property and Patents · Medicine · Nursing · Pharmaceutical Economics and Policy · Pharmaceutical Quality and Counterfeiting · Psychology · Internal Medicine
| Citations per year | 0.5 |
|---|---|
| Citation span | 2022 - 2025 (4) |
| Highly cited | No |